Key result
Mibefradil blocked T-type calcium currents with an IC50 of 0.1 microM and displayed voltage- and use-dependent inhibition of L-type calcium currents.
Why the study?
Does mibefradil inhibit T-type and L-type calcium channels in cardiac cells?
Does mibefradil inhibit T-type and L-type calcium channels in cardiac cells?
Mibefradil's inhibition of L-type calcium channels is voltage- and use-dependent and has likely been underestimated, potentially accounting for most of its cardiovascular effects.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for predominant L-type effects; leaves open human translation from animal cardiac cells.
Ca2+ channel antagonists of the dihydropyridine, benzothiazepine, and phenylalkylamine classes have selective effects on L-type versus T-type Ca2+ channels. In contrast, mibefradil was reported to be more selective for T-type channels. We used the whole-cell patch-clamp technique to investigate the effects of mibefradil on T-type and L-type Ca2+ currents (I(CaT) and I(CaL)) recorded at physiologic extracellular Ca2+ in different cardiac cell types. At a stimulation rate of 0.1 Hz, mibefradil blocked I(CaT) evoked from negative holding potentials (HPs) (-100 mV to -80 mV) with an IC50 of 0.1 microM in rat atrial cells. This concentration had no effect on I(CaL) in rat ventricular cells (IC50: approximately3 microM). However, block of I(CaL) was enhanced when the HP was depolarized to -50 mV (IC50: approximately 0.1 microM). Besides a resting block, mibefradil displayed voltage- and use-dependent effects on both I(CaT) and I(CaL). In addition, inhibition was enhanced by increasing the duration of the step-depolarizations. Similar effects were observed in human atrial and rabbit sinoatrial cells. In conclusion, mibefradil combines the voltage- and use-dependent effects of dihydropyridines and benzothiazepines on I(CaL). Inhibition of I(CaL), which has probably been underestimated before, may contribute to most of the cardiovascular effects of mibefradil.
No takes yet. Share an insight, caveat, or question.
Leuranguer et al. (2001) studied this question. Mibefradil was evaluated on Inhibition of T-type and L-type Ca2+ currents (IC50). Mibefradil blocked T-type calcium currents with an IC50 of 0.1 microM and displayed voltage- and use-dependent inhibition of L-type calcium currents.
Synapse has enriched 10 related papers. Consider them for comparative context: